Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
26,001,449
-
Share change
-
+404,173
-
Total reported value
-
$196,242,684
-
Put/Call ratio
-
101%
-
Price per share
-
$7.55
-
Number of holders
-
77
-
Value change
-
+$2,247,655
-
Number of buys
-
35
-
Number of sells
-
42
Institutional Holders of HARPOON THERAPEUTICS INC - COM (HARP) as of Q4 2021
As of 31 Dec 2021,
HARPOON THERAPEUTICS INC - COM (HARP) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,001,449 shares.
The largest 10 holders included
BIOIMPACT CAPITAL LLC, New Leaf Venture Partners, L.L.C., MPM ASSET MANAGEMENT LLC, ORBIMED ADVISORS LLC, Logos Global Management LP, BlackRock Inc., VANGUARD GROUP INC, FRANKLIN RESOURCES INC, Artal Group S.A., and Candriam Luxembourg S.C.A..
This page lists
77
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.